InfuSystem Holdings Inc (INFU)

AMEX · Healthcare · Medical Devices · USA

InfuSystem Holdings Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.

InfuSystem Holdings Inc delivers durable medical equipment and support services to cancer clinics, hospitals, and surgical centers throughout the United States and Canada. The company operates two business units: Patient Services, which provides electronic infusion pumps and related supplies for home-based chemotherapy treatment, and Device Solutions, offering equipment rentals, consumables, and biomedical maintenance services.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the InfuSystem Holdings Inc stock.

Our verdict on INFU

Slightly overvalued: intrinsic value $13.10 per share, market price $14.79, margin of safety -12.9% (as of 2026-11-17).

Discounting its cash flows at 10.9% (average of 3 methods) values the shares at $13.10; the price of $14.79 is 13% above that value, and 70% of that value comes from beyond year five.

ETFs with the most weight in INFU

17 more funds hold it; the full list is part of the paid plan.

More on INFU

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than INFU in Medical Devices

17 more in this industry show a wider margin of safety.

Is INFU undervalued or overvalued?

INFU is slightly overvalued (as of the 2026-11-17 close). Discounting its cash flows at 10.9% (average of 3 methods) values the shares at $13.10; the price of $14.79 is 13% above that value, and 70% of that value comes from beyond year five.

What is the intrinsic value of INFU?

$13.10 per share (as of the 2026-11-17 close), against a market price of $14.79. That is a margin of safety of -12.9%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.